Cannabis

Amyris Scales up Cannabinoid Process

Synthetic biotech company Amyris said it has successfully scaled up commercial production of cannabigerol (CBG) through leveraging its industrial fermentation process capability. The precursor from which all other cannabinoids are synthesized, CBG is a non-psychoactive cannabinoid that is said to present significant therapeutic potential.